Vir Biotechnology Income Statement (2018-2026) | VIR

Income Statement Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Revenue & cost
Revenue (Quarter)
168.30M103.62M812.75M1,232.46M40.63M374.56M49.41M62.96M3.80M2.64M16.79M51.70M3.08M2.38M12.37M3.03M1.21M0.24M64.07M0.03M
Gross Profit (Quarter)
167.16M95.78M755.87M1,142.31M12.71M352.30M43.41M61.05M3.77M2.60M15.99M51.64M3.02M2.33M11.69M3.03M1.20M
Operating items
Amortization - Intangibles (Quarter)
0.10M0.01M0.17M0.39M2.20M9.33M16.17M21.31M23.02M21.93M20.74M21.28M18.85M
Research & Development (Quarter)
86.13M98.67M128.34M90.23M115.08M114.17M155.17M157.64M168.08M145.03M108.97M100.12M105.11M195.18M106.08M118.64M97.51M151.46M88.35M108.92M
Selling, General & Administrative (Quarter)
28.78M50.50M55.78M38.26M41.59M43.17M38.74M46.78M45.51M40.93M41.22M36.32M30.27M25.74M26.70M23.94M22.28M22.23M23.62M23.34M
Other Operating Expenses (Quarter)
1.14M7.84M56.88M90.15M27.92M22.25M6.00M1.91M5.39M3.41M5.62M0.01M26.33M12.76M-3.26M-0.01M-0.16M-0.01M0.03M
Operating Expenses (Quarter)
116.05M157.00M241.00M218.63M184.59M179.59M199.91M206.33M218.98M189.37M155.80M136.46M161.71M233.68M129.52M142.58M119.63M173.68M111.99M132.26M
Operating Income (Quarter)
61.02M-53.38M571.75M1,013.83M-225.22M194.96M-150.50M-143.37M-215.19M-186.73M-139.02M-80.08M-158.63M-231.30M-117.15M-139.55M-118.42M-173.44M-47.92M-132.29M
EBIT (Quarter)
61.02M-53.38M571.75M1,013.83M-225.22M194.96M-150.50M-143.37M-215.19M-186.73M-139.02M-80.08M-158.63M-231.30M-117.15M-139.55M-118.42M-173.44M-47.92M-132.29M
Non-operating items
Interest & Investment Income (Quarter)
21.93M20.74M21.28M18.85M17.53M14.15M12.29M10.79M9.36M7.80M7.19M
Other Non Operating Income (Quarter)
0.75M0.06M-0.01M2.73M0.69M27.03M-26.19M-8.02M-0.37M0.88M-1.49M-0.29M-0.54M-0.89M-0.51M-0.07M0.23M-0.23M-0.34M-0.25M
Non Operating Income (Quarter)
0.85M164.15M-25.86M-91.92M-8.50M22.77M-109.23M-8.02M25.77M20.11M18.26M15.08M-0.54M-0.89M-0.51M18.60M0.23M-0.23M41.63M6.76M
Net income details
EBT (Quarter)
61.87M110.76M545.89M921.91M-233.72M217.73M-151.64M-143.19M-197.62M-166.63M-120.76M-65.00M-139.89M-213.54M-104.67M-120.95M-110.79M-162.97M-43.06M-125.53M
Tax Provisions (Quarter)
0.05M0.33M20.64M403.29M-157.23M42.42M-50.03M-2.23M-2.85M-3.21M-4.78M0.28M-1.51M0.18M-0.09M0.02M0.17M0.17M-0.14M0.17M
Profit After Tax (Quarter)
61.81M110.43M525.25M518.62M-76.49M175.31M-101.60M-140.96M-194.78M-163.41M-115.97M-65.28M-138.38M-213.72M-104.59M-120.97M-110.96M-163.14M-42.92M-125.69M
Equity Income (Quarter)
164.07M-26.02M-95.04M-11.39M-13.59M8.92M-13.10M-5.09M-2.70M-1.00M-5.92M0.40M1.13M-1.17M6.38M-3.38M1.33M-2.60M-0.17M
Income from Continuing Operations (Quarter)
61.81M110.43M525.25M518.62M-76.49M175.31M-101.60M-140.96M-194.78M-163.41M-115.97M-65.28M-138.38M-213.72M-104.59M-120.97M-110.96M-163.14M-42.92M-125.69M
Consolidated Net Income (Quarter)
61.81M110.43M525.25M518.62M-76.49M175.31M-101.60M-140.96M-194.78M-163.41M-115.97M-65.28M-138.38M-213.72M-104.59M-120.97M-110.96M-163.14M-42.92M-125.69M
Income towards Parent Company (Quarter)
61.81M110.43M525.25M518.62M-76.49M175.31M-101.60M-140.96M-194.78M-163.41M-115.97M-65.28M-138.38M-213.72M-104.59M-120.97M-110.96M-163.14M-42.92M-125.69M
Net Income towards Common Stockholders (Quarter)
61.81M110.43M525.25M518.62M-76.49M175.31M-101.60M-140.90M-194.78M-163.41M-115.97M-65.28M-138.38M-213.72M-104.59M-120.97M-110.96M-163.14M-42.92M-125.69M
Additional items
EPS (Basic) (Quarter)
0.480.854.043.93-0.581.32-0.77-1.06-1.45-1.22-0.86-0.48-1.02-1.56-0.76-0.88-0.80-1.17-0.30-0.85
EPS (Weighted Average and Diluted) (Quarter)
0.460.823.943.85-0.581.30-0.75-1.06-1.45-1.22-0.86-0.48-1.02-1.56-0.76-0.88-0.80-1.17-0.30-0.85
Shares Outstanding (Weighted Average) (Quarter)
130.12M130.67M129.88M132.08M132.33M132.73M132.61M133.55M134.06M133.97M134.13M135.28M136.22M136.06M136.25M137.47M138.45M138.29M138.52M147.36M
Shares Outstanding (Diluted Average) (Quarter)
133.44M134.64M134.96M134.81M133.55M133.81M134.29M134.13M135.28M136.22M136.06M136.25M137.47M138.45M138.29M138.52M147.36M
EBITDA (Quarter)
61.02M-53.38M571.75M1,013.83M-225.22M194.96M-150.50M-143.37M-215.19M-186.73M-139.02M-80.08M-158.63M-231.30M-117.15M-139.55M-118.42M-173.44M-47.92M-132.29M
Shares Outstanding (Quarter)
130.48M130.83M131.16M132.35M132.60M133.03M133.24M133.93M134.23M134.50M134.78M135.84M136.59M136.71M136.96M138.06M138.89M139.02M139.47M161.23M
Tax Rate (Quarter)
0.090.303.7843.7467.2719.4833.001.561.441.933.96-0.421.08-0.080.08-0.01-0.15-0.100.32-0.14